4.4 Article

The Alzheimer's Disease Clinical Spectrum Diagnosis and Management

Journal

MEDICAL CLINICS OF NORTH AMERICA
Volume 103, Issue 2, Pages 263-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2018.10.009

Keywords

Alzheimer's disease; Mild cognitive impairment; Cognitive; Treatment; Donepezil; Memantine; Neuroimaging; Review

Ask authors/readers for more resources

Alzheimer's disease (AD) care requires timely diagnosis and multidisciplinary management. Evaluation involves structured patient and caregiver history and symptom-function reviews, examination, and testing (laboratory and neuroimaging) to delineate impairment level, determine the cognitive-behavioral syndrome, and diagnose cause. Clinical biomarkers are available to aid high confidence in etiologic diagnosis. Management uses psychoeducation, shared goal setting, and patient-caregiver dyad decision making. When combined, pharmacologic and nonpharmacologic therapies mitigate symptoms and reduce clinical progression and care burden. AD biopathologic processes develop over decades before symptoms manifest; this period is increasingly targeted in research as an opportunity to best delay or prevent AD dementia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available